Virologic failure after 48 weeks of raltegravir-based regimen in low HIV-1 incidence setting.

Abstract excerpt

BACKGROUND: With the advent of next generation integrase strand transfer inhibitors, the rates of virologic failure in treated subjects are expected to decrease. In this study, we analyzed the mutation patterns leading to virologic failure before and after starting integrase strand transfer inhibitor-based regimen as first-line or salvage therapy. METHODS: Between 2016 and 2019, blood samples were received from...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Child
• Share to Child, Preschool
• Share to Drug Resistance, Viral